Quotes 5-day view Delayed Swiss Exchange
11/23/2020
11/24/2020
11/25/2020
11/26/2020
11/27/2020
Date
302.15(c)
300.55(c)
300.15(c)
303.1(c)
302.5(c)
Last
2 314 169
3 319 931
2 564 685
1 624 983
2 015 268
Volume
-0.84% -0.53% -0.13% +0.98% -0.20% Change
Sales 2020
59 977 M 66 287 M 66 287 M
Net income 2020
14 353 M 15 863 M 15 863 M
Net cash position 2020
3 530 M 3 901 M 3 901 M
P/E ratio 2020
18,3x
Yield 2020
3,07%
Sales 2021
62 782 M 69 387 M 69 387 M
Net income 2021
15 560 M 17 197 M 17 197 M
Net cash position 2021
11 571 M 12 788 M 12 788 M
P/E ratio 2021
16,7x
Yield 2021
3,18%
Capitalization
259 B 286 B 286 B
EV / Sales 2020
4,25x
EV / Sales 2021
3,94x
Nbr of Employees
97 735
Free-Float
83,6%
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The...
All news about ROCHE HOLDING AG
News in other languages on ROCHE HOLDING AG
Analyst Recommendations on ROCHE HOLDING AG
ROCHE HOLDING AG - 08/19
Close to an important medium term support level
BUY
Business rights or human rights? Swiss vote shines spotlight on companies
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ROCHE HOLDING AG
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
25
Average target price
375,80 CHF
Last Close Price
302,50 CHF
Spread / Highest target
44,1%
Spread / Average Target
24,2%
Spread / Lowest Target
-5,79%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
